Patient-reported long-term outcome following allogeneic hematopoietic stem cell transplantation in pediatric chronic myeloid leukemia

BACKGROUND: Pediatric CML is very rare. Before the introduction of tyrosine kinase inhibitors (TKIs), allogeneic hematopoietic stem cell transplantation (HSCT) from a donor -if available- was the standard cure attempt. Data on the long-term outcome and health-related quality of life (HRQOL) in forme...

Descripción completa

Detalles Bibliográficos
Autores principales: Schleicher, Oliver, Horndasch, Annkathrin, Krumbholz, Manuela, Sembill, Stephanie, Bremensdorfer, Claudia, Grabow, Desiree, Erdmann, Friederike, Karow, Axel, Metzler, Markus, Suttorp, Meinolf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9580018/
https://www.ncbi.nlm.nih.gov/pubmed/36276159
http://dx.doi.org/10.3389/fonc.2022.963223

Ejemplares similares

Ejemplares similares